• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于生物发光的血清杀菌试验,用于检测人血清中针对[具体细菌或病原体,此处原文未明确]的杀菌抗体。

A Bioluminescence-Based Serum Bactericidal Assay to Detect Bactericidal Antibodies Against in Human Sera.

作者信息

Fantoni Giulia, Deghmane Ala-Eddine, Caron François, Taha Muhamed-Kheir

机构信息

Institut Pasteur, Invasive Bacterial Infections, Université Paris Cité, F-75006 Paris, France.

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.

出版信息

Microorganisms. 2025 Mar 4;13(3):595. doi: 10.3390/microorganisms13030595.

DOI:10.3390/microorganisms13030595
PMID:40142487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11944440/
Abstract

Serum bactericidal assay (SBA) is a functional assay that evaluates infection- and vaccine-induced neutralizing antibodies representing the serological correlate of protection against . However, it is time consuming due to its readout using the enumeration of colony-forming units (CFUs), making this conventional SBA (C-SBA) difficult for large-scale use. We developed a new SBA method that takes advantage of a bioluminescence serogroup B (BioLux-SBA). The assay development steps involved the human complement source validation, the setup of the optimal incubation time, and the assessment of intra-day and inter-day variability. BioLux-SBA was then compared to C-SBA using a serum collection of Norman children vaccinated in 2011 with MenBvac, an OMV meningococcal vaccine. While a conventional approach requests 48 h of work to test 24 sera per day, BioLux-SBA takes only 5 h to test 96 sera per day. The SBA titers (n = 10) correlated with R of 0.98 (-value < 0.0001). The deposition of terminal complement components (C5b-C9) measured by flow cytometry on the bacterial surface well correlated with BioLux SBA titers. This high-throughput method to evaluate the immunogenicity of meningococcal vaccines appears to be a reliable method for an OMV meningococcal B vaccine and requires further assessment in other laboratories and against other meningococcal vaccines.

摘要

血清杀菌试验(SBA)是一种功能性试验,用于评估感染诱导和疫苗诱导的中和抗体,这些抗体代表了针对……的保护性血清学关联指标。然而,由于其通过菌落形成单位(CFU)计数进行读数,耗时较长,使得这种传统的SBA(C-SBA)难以大规模使用。我们开发了一种利用生物发光的新型SBA方法——B群血清型生物发光SBA(BioLux-SBA)。试验开发步骤包括人补体来源验证、最佳孵育时间的设定以及日内和日间变异性评估。然后,使用2011年接种MenBvac(一种外膜囊泡脑膜炎球菌疫苗)的诺曼儿童的血清样本,将BioLux-SBA与C-SBA进行比较。传统方法每天检测24份血清需要48小时的工作量,而BioLux-SBA每天检测96份血清仅需5小时。SBA滴度(n = 10)的相关系数R为0.98(P值<0.0001)。通过流式细胞术测量的细菌表面终末补体成分(C5b-C9)沉积与BioLux SBA滴度高度相关。这种评估脑膜炎球菌疫苗免疫原性的高通量方法似乎是一种用于外膜囊泡B群脑膜炎球菌疫苗的可靠方法,需要在其他实验室针对其他脑膜炎球菌疫苗进行进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/ba266f41ef7e/microorganisms-13-00595-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/59dc3975a527/microorganisms-13-00595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/85f513560f73/microorganisms-13-00595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/ed0154ccae0e/microorganisms-13-00595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/a452144c92ed/microorganisms-13-00595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/69572573b616/microorganisms-13-00595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/4268a4f2b665/microorganisms-13-00595-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/ba266f41ef7e/microorganisms-13-00595-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/59dc3975a527/microorganisms-13-00595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/85f513560f73/microorganisms-13-00595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/ed0154ccae0e/microorganisms-13-00595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/a452144c92ed/microorganisms-13-00595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/69572573b616/microorganisms-13-00595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/4268a4f2b665/microorganisms-13-00595-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e45/11944440/ba266f41ef7e/microorganisms-13-00595-g007.jpg

相似文献

1
A Bioluminescence-Based Serum Bactericidal Assay to Detect Bactericidal Antibodies Against in Human Sera.一种基于生物发光的血清杀菌试验,用于检测人血清中针对[具体细菌或病原体,此处原文未明确]的杀菌抗体。
Microorganisms. 2025 Mar 4;13(3):595. doi: 10.3390/microorganisms13030595.
2
Use of expanded serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness.使用扩展的B群血清组进行血清杀菌抗体检测以评估B群脑膜炎球菌疫苗的有效性。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):738-748. doi: 10.1080/14760584.2023.2244596.
3
Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.A群和C群脑膜炎奈瑟菌血清杀菌试验的标准化及多实验室比较。多实验室研究小组。
Clin Diagn Lab Immunol. 1997 Mar;4(2):156-67. doi: 10.1128/cdli.4.2.156-167.1997.
4
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.挪威B群脑膜炎球菌外膜囊泡疫苗MenBvac三剂接种后B群脑膜炎奈瑟菌免疫测定结果与人体抗体反应的比较及相关性
Infect Immun. 2006 Aug;74(8):4557-65. doi: 10.1128/IAI.00466-06.
5
Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.开发一种高通量方法,以细菌ATP测量作为存活读数来评估血清杀菌活性。
PLoS One. 2017 Feb 13;12(2):e0172163. doi: 10.1371/journal.pone.0172163. eCollection 2017.
6
In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway.在接种疫苗的个体中,血清杀菌活性针对 B 型脑膜炎球菌被 C5 抑制所消除,但不会被替代补体途径的抑制所消除。
Front Immunol. 2023 Jun 29;14:1180833. doi: 10.3389/fimmu.2023.1180833. eCollection 2023.
7
Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody.成人对B群脑膜炎奈瑟菌具有免疫力,尽管缺乏血清杀菌抗体。
Clin Vaccine Immunol. 2007 Dec;14(12):1596-602. doi: 10.1128/CVI.00341-07. Epub 2007 Oct 3.
8
[Comparison on the levels of human serum antibody against Neisseria meningitidis serogroup C measured using serum bactericidal assay and ELISA].[采用血清杀菌试验和酶联免疫吸附测定法检测的人血清抗C群脑膜炎奈瑟菌抗体水平比较]
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 May;33(5):521-4.
9
Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine.在接种挪威MenBvac外膜囊泡疫苗前后,使用人补体针对脑膜炎奈瑟菌B群44/76 - SL菌株进行血清杀菌活性测量的实验室间标准化。
Clin Diagn Lab Immunol. 2005 Aug;12(8):970-6. doi: 10.1128/CDLI.12.8.970-976.2005.
10
Durability of immunogenicity and strain coverage of MenBvac, a meningococcal vaccine based on outer membrane vesicles: Lessons of the Normandy campaign.基于外膜囊泡的脑膜炎球菌疫苗MenBvac的免疫原性持久性和菌株覆盖范围:诺曼底战役的经验教训。
Vaccine. 2017 Jul 13;35(32):4029-4033. doi: 10.1016/j.vaccine.2017.05.065. Epub 2017 Jun 16.

本文引用的文献

1
Development and validation of a standardized human complement serum bactericidal activity assay to measure functional antibody responses to Neisseria gonorrhoeae.一种用于测量针对淋病奈瑟菌的功能性抗体反应的标准化人补体血清杀菌活性测定法的开发与验证。
Vaccine. 2025 Jan 1;43(Pt 2):126508. doi: 10.1016/j.vaccine.2024.126508. Epub 2024 Nov 15.
2
Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA).提高基于发光的血清杀菌试验(L-SBA)的高通量
BioTech (Basel). 2021 Sep 18;10(3):19. doi: 10.3390/biotech10030019.
3
Generation of a Universal Human Complement Source by Large-Scale Depletion of IgG and IgM from Pooled Human Plasma.
通过从人血浆中大规模耗尽 IgG 和 IgM 生成通用人类补体源。
Methods Mol Biol. 2022;2414:341-362. doi: 10.1007/978-1-0716-1900-1_18.
4
Correlates of protection for meningococcal surface protein vaccines: lessons from the past.脑膜炎球菌表面蛋白疫苗的保护相关因素:从过去中吸取的教训。
Expert Rev Vaccines. 2022 Jun;21(6):739-751. doi: 10.1080/14760584.2021.1940144. Epub 2021 Jul 21.
5
Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B.用于评估针对B群脑膜炎球菌疫苗效力的内源性补体人血清杀菌试验(enc-hSBA)
NPJ Vaccines. 2021 Feb 23;6(1):29. doi: 10.1038/s41541-021-00286-8.
6
Evidence for Multi-Organ Infection During Experimental Meningococcal Sepsis due to ST-11 Isolates in Human Transferrin-Transgenic Mice.人转铁蛋白转基因小鼠中由ST-11分离株引起的实验性脑膜炎球菌败血症期间多器官感染的证据。
Microorganisms. 2020 Sep 23;8(10):1456. doi: 10.3390/microorganisms8101456.
7
Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.脑膜炎奈瑟菌尿道炎暴发分离株表达一种新型因子 H 结合蛋白变异体,可能成为 B 群脑膜炎奈瑟菌(MenB)疫苗的潜在靶点。
Infect Immun. 2020 Nov 16;88(12). doi: 10.1128/IAI.00462-20.
8
First Real-world Evidence of Meningococcal Group B Vaccine, 4CMenB, Protection Against Meningococcal Group W Disease: Prospective Enhanced National Surveillance, England.首个脑膜炎奈瑟菌 B 群疫苗 4CMenB 预防脑膜炎奈瑟菌 W 群疾病的真实世界证据:英格兰全国前瞻性强化监测。
Clin Infect Dis. 2021 Oct 5;73(7):e1661-e1668. doi: 10.1093/cid/ciaa1244.
9
Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies.总补体和部分补体缺陷的大样本临床和遗传学特征。
Front Immunol. 2019 Aug 8;10:1936. doi: 10.3389/fimmu.2019.01936. eCollection 2019.
10
A review of complement sources used in serum bactericidal assays for evaluating immune responses to meningococcal ACWY conjugate vaccines.评价脑膜炎奈瑟球菌 ACWY 结合疫苗免疫反应的血清杀菌试验中使用的补体来源的综述。
Hum Vaccin Immunother. 2019;15(10):2491-2500. doi: 10.1080/21645515.2019.1593082. Epub 2019 Apr 23.